Mara Aspinall

Professor of Practice (FSC)

Calculated based on number of publications stored in Pure and citations from Scopus
20022021

Research activity per year

Network

Cedric Francois

  • President and CEO
  • Apellis Pharmaceuticals
  • Apellis Pharmaceuticals
  • Blaze Bioscience, Inc.

External person

Martin Babler

  • Principia Biopharma Inc.
  • Principa Biopharma
  • Principia Biopharma

External person

James E. Audia

  • Third Rock Ventures
  • Constellation Pharmaceuticals, Inc.

External person

Jeremy Levin

  • The European Association for Bioindustries
  • Biotechnology Innovation Organization
  • Chairman and CEO
  • Ovid Therapeutics
  • Biotechnology Industry Organization

External person

Robert Blum

  • Cytokinetics, Inc.

External person

Peter Barrett

  • Atlas Venture

External person

Chip Clark

  • Genocea Biosciences, Inc.
  • Flexion Therapeutics Inc.

External person

Chris Adams

  • Cydan II Inc.

External person

Douglas Doerfler

  • MaxCyte, Inc
  • NeuroPoint Dx

External person

John Maraganore

  • The European Association for Bioindustries
  • Alnylam Pharmaceuticals

External person

Ron Cohen

  • Acorda Therapeutics, Inc

External person

Michael Bonney

  • Kaleido Biosciences
  • Alnylam Pharmaceuticals
  • Magenta
  • Kaleido Biosciences

External person

Jeffrey Cleland

  • President and CEO
  • Ashvatta Therapeutics
  • Graybug Vision

External person

Daniel A. de Boer

  • CEO
  • ProQR Therapeutics

External person

Brook Byers

  • Partner
  • Kleiner Perkins Caulfield Byers
  • Tizona Therapeutics

External person

Rachel King

  • GlycoMimetics, Inc.
  • Luc Therapeutics, Inc.

External person

Paul Hastings

  • President and CEO
  • Nkarta Therapeutics
  • OncoMed Pharmaceuticals

External person

Paul Bolno

  • President and CEO
  • Wave Life Sciences

External person

Ted W. Love

  • Global Blood Therapeutics, Inc.
  • Tetraphase Pharmaceuticals

External person

Bruce Booth

  • Atlas Venture
  • Amylin Pharmaceuticals Incorporated

External person

Isaac Ciechanover

  • Atara Biotherapeutics, Inc.
  • Genocea Biosciences, Inc.

External person

Ivan Coulter

  • Managing Director
  • Eden Biopharma

External person

John Cashman

  • Human BioMolecular Research Institute

External person

Sara Jane Demy

  • Founder and CEO
  • Demy-Colton

External person

Christiana Bardon

  • Partner
  • MPM Impact Fund

External person

Jacob Becraft

  • Strand Therapeutics

External person

J. F. Formela

  • Atlas Venture
  • Verastem Oncology

External person

Eric Dube

  • President and CEO
  • Retrophin, Inc.

External person

Michael D. Clayman

  • Flexion Therapeutics Inc.
  • Graybug Vision

External person

Marina Bozilenko

  • William Blair and Company

External person

Steven R. Deitcher

  • Radimmune Therapeutics, Inc.

External person

Jeffrey Albers

  • Blueprint Medical Corporation

External person

Michelle McMurry-Heath

  • Biotechnology Innovation Organization
  • Biotechnology Industry Organization

External person

Jeffrey Bacha

  • Edison Oncology Holding Corp.

External person

Christopher R. Anzalone

  • President and CEO
  • Arrowhead Pharmaceuticals

External person

Karim Dabbagh

  • President and CEO
  • Second Genome

External person

Mark Barrett

  • CEO
  • Lasson Therapeutics

External person

Tony De Fougerolles

  • CEO
  • Evox Therapeutics Limited
  • Evox Therapeutics

External person

Steven Holtzman

  • Decibel Therapeutics, Inc.

External person

Julian Adams

  • Gamida Cell
  • Clal Biotechnology Industries (CBI)

External person

Sarah Boyce

  • CEO
  • Avidity Biosciences LLC

External person

Gerald F. Cox

  • Gerald Cox Rare Care Consulting LLC

External person

Neil Exter

  • Third Rock Ventures
  • Q-State Biosciences

External person

Robert Forrester

  • Verastem Oncology
  • Apellis Pharmaceuticals

External person

Michael P. Bailey

  • AVEO Oncology

External person

Katrine S. Bosley

  • Chairman of the Board
  • Arrakis Therapeutics

External person

John Crowley

  • Chairman and CEO
  • Amicus Therapeutics

External person

Jim Burns

  • CEO
  • Locanabio

External person

Daniel M. Bradbury

  • Equillium, Inc.
  • Salus Discovery LLC

External person

Jeffrey Bird

  • Bluebird Ventures
  • Bluebird Ventures

External person

Brian Chee

  • Polaris Partners

External person

Devon Cayer

  • 1859 Inc.

External person

Alan Crane

  • Polaris Partners

External person

Kevin Bitterman

  • Atlas Venture

External person

Brian Culley

  • CEO
  • Lineage Cell Therapeutics

External person

Deborah Dunsire

  • H. Lundbeck A/S
  • Ovid Therapeutics

External person

Sunny Al-Shamma

  • President and CEO
  • Beacon Discovery

External person

Stuart L. Schreiber

  • Harvard University
  • Howard Hughes Medical Institute
  • Broad Institute
  • Department of Molecular and Cellular Biology
  • Massachusetts Institute of Technology
  • Department of Chemistry and Chemical Biology
  • Department of Molecular and Cellular Biology
  • 5AM Ventures

External person

Rob Perez

  • BVF Partners

External person

Jonas Binding

  • RapidTestsDE

External person

Amit Rakhit

  • Ovid Therapeutics
  • Encoded Genomics

External person

Jason Rhodes

  • Atlas Venture
  • Inc.

External person

Nick Leschly

  • Bluebird Bio
  • RA Capital Management, LLC

External person

David V. Goeddel

  • The Column Group
  • Revolution Medicines, Inc.

External person

J. C. Gutierrez-Ramos

  • Dragonfly Therapeutics, Inc.

External person

Brianna Desharnais

  • Simmons College

External person

George P. Vlasuk

  • Navitor Pharmaceuticals, Inc.
  • Biogen IDEC

External person

Paul Laikind

  • ViaCyte, Inc.
  • Massachusetts Institute of Technology

External person

Tim Harris

  • FSG Biotech

External person

Eric Elenko

  • Third Rock Ventures

External person

Larry Miller

  • Adaptive Biotechnologies

External person

Arthur L. Caplan

  • Center for Healthful Behavior Change
  • New York University

External person

Neil Warma

  • General Manager
  • I-Mab Biopharma U.S.
  • Denali Therapeutics

External person

Brian M. Cali

  • Atara Biotherapeutics, Inc.

External person

William J. Rieflin

  • Adaptive Biotechnologies

External person

John K. Clarke

  • Cardinal Partners

External person

Steven K. Brauer

  • Biotech Venture Capitalist since 1978

External person

Michel Vounatsos

  • Biogen IDEC
  • MeiraGTx

External person

Richard Ulevitch

  • Alnylam Pharmaceuticals

External person

Alan Levy

  • Tasso, Inc.
  • Editas Medicine

External person

Wendy Nelson

  • Sutro Biopharma, Inc.

External person

Sean McCarthy

  • CytomX Therapeutics
  • Sobi, Inc.

External person

Andrew Schwab

  • Lycera Corporation

External person

Mark A. Goldsmith

  • Trevena, Inc.

External person

Doug E. Williams

  • Five Prime Therapeutics, Inc.

External person

Paul Grint

  • Synlogic

External person

Daniel Dornbusch

  • Dornbusch & Company

External person

Elisabet de los Pinos

  • Aura Biosciences, Inc.

External person

Maureen Johnson-León

  • University of Texas at Austin
  • University of Idaho

External person

Michael A. Narachi

  • Polaris Partners

External person

Brian M. Gallagher

  • Juniper Pharmaceuticals

External person

Maureen N. Franco

  • Cambridge BioMarketing

External person

James M. Crawford

  • Hofstra University
  • Northwell Health System

External person

Jean Kim

  • Centrexion Therapeutics Inc.

External person

Jeff Kaplan

  • Intellia Therapeutics

External person

Ronald A. DePinho

  • Harvard University
  • University of Texas MD Anderson Cancer Center
  • Dana-Farber Cancer Institute
  • Belfer Institute for Applied Cancer Science
  • Department of Medicine and Genetics

External person

Rajeev Shah

  • Lewis Thomas Laboratory

External person

Eugene Braunwald

  • Harvard University

External person

Uri Lopatin

  • Assembly Biosciences, Inc.
  • Global Blood Therapeutics, Inc.

External person

Jean Jacques Bienaime

  • BioMarin Pharmaceutical Inc.

External person

Yujiro Steve Hata

  • Ironwood Pharmaceuticals

External person

Wende Hutton

  • Canaan Partners
  • Aduro Biotech, Inc

External person

Steve Paul

  • Karuna Pharmaceuticals Inc
  • GE Life Sciences

External person

Clay B. Siegall

  • Clarus Ventures LLC

External person

Jonathan J. Fleming

  • OticPharma Inc.

External person

Tuan Ha-Ngoc

  • SV Life Sciences

External person

Amir Nashat

  • Polaris Partners
  • Boston Biotech Forum

External person

Guy MacDonald

  • Antiva Biosciences, Inc.

External person

Tom Graney

  • Atlas Venture

External person

Jonathan Leff

  • Deerfield
  • Momenta Pharmaceuticals, Inc.

External person

Chad Robins

  • 5AM Ventures

External person

Richard G. Hamermesh

  • Harvard University

External person

John E. Osborn

  • BioVentures/Egalet Corporation
  • Millendo Therapeutics, Inc.

External person

Camille Samuels

  • Venrock
  • Harvard University

External person

Herve Hoppenot

  • Massachusetts Institute of Technology

External person

Mark G. Currie

  • 5AM Ventures

External person

David Clem

  • Lyme Properties 2, LLC

External person

Gail J. Maderis

  • Spero Therapeutics

External person

Burkhard Blank

  • Acorda Therapeutics, Inc

External person

George Scangos

  • Vir Biotechnology, Inc.
  • Geron Corporation

External person

Jeff Kindler

  • GlycoMimetics, Inc.

External person

Matthew Perry

  • Third Rock Ventures

External person

Heather Franklin

  • Blaze Bioscience, Inc.
  • 5AM Ventures

External person

James G. McArthur

  • Pear Therapeutics, Inc.

External person

Gustav Christensen

  • Morphic Therapeutic

External person

Cherie Lynn Ramirez

  • Harvard University
  • Simmons College
  • Ariadne Labs

External person

David Baltimore

  • California Institute of Technology
  • Organizing Committee for the International Summit on Human Gene Editing

External person

Bob More

  • Harvard University

External person

S. D. Freedman

  • Harvard University
  • Division of Gastroenterology
  • Division of Translational Research
  • Beth Israel Deaconess Medical Center

External person

John A. Scarlett

  • Geron Corporation
  • Agios

External person

Mary T. Szela

  • CEO
  • TriSalus Life Sciences
  • Inc.

External person

Nina Kjellson

  • General Partner
  • Canaan
  • Macrogenics, Inc.

External person

Jeb Keiper

  • Deerfield

External person

Paul Sekhri

  • eGenesis, Inc.
  • Lycera Corporation
  • RA Capital Management, LLC

External person

Elizabeth Lr Donley

  • Southern Cross Biotech Consulting

External person

Kleanthis Xanthopoulos

  • Irras
  • PureTech Health plc

External person

Samuel G. Waksal

  • Opexa Therapeutics, Inc.

External person

Arnold J. Levine

  • Chrono Therapeutics

External person

Gary Palmer

  • On-Q-ity Inc.

External person

Ryan J. Watts

  • Ovid Therapeutics

External person

Iain Buchan

  • University of Liverpool

External person

Robert Langer

  • Massachusetts Institute of Technology
  • Decibel Therapeutics, Inc.

External person

Mark Levin

  • Third Rock Ventures
  • Institute for Advanced Studies

External person

James A. Geraghty

  • Evelo Biosciences, Inc.

External person

Scott M. Rocklage

  • 5AM Ventures
  • Flagship Pioneering

External person

Bruce A. Leicher

  • Bluebird Bio

External person

Jens W. Eckstein

  • PureTech Health plc

External person

Peter Hecht

  • Deerfield

External person

Leonard Patrick Gage

  • Clarus Ventures

External person

Alex Martin

  • Akili Interactive Labs, Inc.

External person

Thomas Shenk

  • ASM
  • Princeton University
  • Seattle Genetics, Inc.

External person

Joel F. Martin

  • Realm Therapeutics

External person

Faheem Hasnain

  • Chairman
  • Mirati Therapeutics
  • Gossamer Bio
  • IDEAYA Biosciences

External person

Perry Karsen

  • Chair
  • Board of Directors
  • Nimbus Therapeutics

External person

Phoebe Olhava

  • St. Elizabeth's Medical Center

External person

Thomas E. Hughes

  • Canaan Partners

External person

Gerhard Koenig

  • RA Capital Management, LLC

External person

Nessan Bermingham

  • Intellia Therapeutics

External person

Kartik Ramamoorthi

  • Neurocrine Biosciences Inc.

External person

Simba Gill

  • Evelo Biosciences, Inc.
  • The Column Group

External person

John P. Butler

  • Akebia Therapeutics

External person

Ankit Mahadevia

  • Scholar Rock, Inc.

External person

Barry Greene

  • Alnylam Pharmaceuticals
  • Regulus Therapeutics LLC

External person

Stephen Bloch

  • Canaan Partners

External person

John Diekman

  • Seattle Genetics, Inc.

External person

Matthew J. During

  • Thomas Jefferson University
  • University of Auckland
  • SR One

External person

Paula Cobb

  • Albireo Pharma Inc.

External person

Scott Koenig

  • Macrogenics, Inc.
  • Quartet Medicine

External person

Zoltan Csimma

  • Csimma LLC

External person

Corey M. McCann

  • Pear Therapeutics, Inc.
  • CytomX Therapeutics

External person

Sandford Zweifach

  • Nuvelution Pharmaceuticals, Inc.

External person

Leah Fesi

  • Education Plus Health

External person

Bernat Olle

  • Vedanta Biosciences, Inc.
  • BioVentures/Egalet Corporation

External person

David R. Liu

  • Harvard University
  • Broad Institute
  • Whitehead Institute for Biomedical Research

External person

William J. Rutter

  • Synergenics
  • Delinia

External person

Eric L. Dobmeier

  • MaxCyte, Inc

External person

Brett Ahrens

  • Canaan Partners

External person

Kenneth I. Moch

  • Centers for Disease Control and Prevention
  • Cognition Therapeutics, Inc.
  • Alta Partners

External person

Ronald Renaud

  • Translate Bio
  • Atlas Venture

External person

Marco Taglietti

  • EpiBone, Inc.

External person

Kush M. Parmar

  • Managing Partner
  • 5AM Ventures
  • Audentes Therapeutics

External person

Atul Pande

  • Regulus Therapeutics LLC

External person

David Schenkein

  • Broad Institute

External person

Emily Costanza

  • Simmons College

External person

Christoph Westphal

  • Partner
  • Longwood Fund
  • TScan Therapeutics
  • Crinetics Pharmaceuticals, Inc.

External person

William Rastetter

  • Adaptimmune Therapeutics

External person

Adrian Rawcliffe

  • Warp Drive Bio

External person

Richard H. Douglas

  • Aldeyra Therapeutics

External person

Daphne Zohar

  • PureTech Health
  • The European Association for Bioindustries
  • PureTech Health plc
  • Nuvelution Pharmaceuticals, Inc.

External person

Laurence E. Reid

  • Translate Bio

External person

William J. Newell

  • Sutro Biopharma, Inc.
  • Vedanta Biosciences, Inc.

External person

Leslie Henshaw

  • Metacrine, Inc.

External person

Stelios Papadopoulos

  • Regulus Therapeutics LLC
  • Biogen IDEC
  • Exelixis Inc.
  • Parker BioConsulting

External person

Howard Furst

  • Tetraphase Pharmaceuticals

External person

Akshay K. Vaishnaw

  • Alnylam Pharmaceuticals
  • AMV Advisors

External person

Charles L. Cooney

  • Massachusetts Institute of Technology

External person

Michael Su

  • Decibel Therapeutics, Inc.
  • Novelion Therapeutics

External person

Ron Cooper

  • Ironwood Pharmaceuticals

External person

David Bartel

  • Whitehead Institute for Biomedical Research

External person

Desmond Nsobila Alugnoa

  • Green Africa Youth Organisation

External person

Nagesh K. Mahanthappa

  • Scholar Rock, Inc.
  • Dauntless Pharmaceuticals, Inc.

External person

C. R. Martin

  • Harvard University
  • Division of Translational Research
  • Department of Neonatology
  • Beth Israel Deaconess Medical Center

External person

H. Stewart Parker

  • Alliance for Regenerative Medicine Foundation
  • 5AM Ventures

External person

Nina Tandon

  • Genzyme Corporation

External person

John Mendlein

  • Macrolide Pharmaceuticals

External person

Diego Miralles

  • Cognition Therapeutics, Inc.

External person

John J. Lee

  • Decibel Therapeutics, Inc.
  • Deerfield

External person

Anne Vanlent

  • Prelude Fertility, Inc.

External person

Stephen T. Isaacs

  • Ultragenyx Pharmaceutical Inc.

External person

Jeff Stein

  • Decibel Therapeutics, Inc.

External person

Andrew G. Myers

  • Orexigen Therapeutics, Inc.

External person

Martin Varsavsky

  • Navitor Pharmaceuticals, Inc.

External person

Nancy Simonian

  • President and CEO
  • Syros Pharmaceuticals
  • Syros Pharmaceuticals
  • Cidara Therapeutics

External person

Dennis J. Purcell

  • Aisling Capital LLC
  • Ovid Therapeutics

External person

Mike Powell

  • Intercept Pharmaceuticals

External person

Wendell Wierenga

  • Crinetics Pharmaceuticals, Inc.
  • Codiak BioSciences

External person

Jeff Jonker

  • Deerfield

External person

Michael Rosenblatt

  • Flagship Pioneering
  • Ironwood Pharmaceuticals

External person

Matthew R. Patterson

  • Voyager Therapeutics

External person

Andrew Levin

  • Third Rock Ventures

External person

Vanessa King

  • Virion Biotherapeutics LLC
  • Canaan Partners

External person

Bill Haney

  • Kew Inc.

External person

Pablo J. Cagnoni

  • Ironwood Pharmaceuticals

External person

Yaron Werber

  • Ovid Therapeutics
  • Flex Pharma

External person

W. Eddie Martucci

  • Akili Interactive Labs, Inc.
  • Imara Inc.

External person

M. Pruzanski

  • Intercept Pharmaceuticals
  • Intercept Pharmaceuticals
  • Intercept
  • Aisling Capital LLC

External person

Nick J. Simon

  • Syros Pharmaceuticals

External person

Peter Kolchinsky

  • RA Capital Management, LLC
  • ViaCyte, Inc.

External person

Louise Kenny

  • University of Liverpool

External person

Cary G. Pfeffer

  • Third Rock Ventures
  • Sofinnova Ventures

External person

Nima Farzan

  • PaxVax, Inc.

External person

Stephane Bancel

  • Moderna Therapeutics

External person

Maxine Gowen

  • Trevena, Inc.
  • SR One, Ltd.

External person

Richard Heyman

  • Chairman of the Board
  • ORIC Pharmaceutical
  • Incyte

External person

N. Anthony Coles

  • Yumanity Therapeutics

External person

Vicki Sato

  • Vir Biotechnology, Inc.

External person

Martin Tolar

  • Alzheon, Inc
  • 5AM Ventures

External person

Michael Aberman

  • Quentis Therapeutics, Inc.

External person

Bruce Carter

  • Novo Nordisk (retired)

External person

Julia C. Owens

  • Millendo Therapeutics, Inc.
  • Verity BioConsulting

External person

Harvey F. Lodish

  • Whitehead Institute for Biomedical Research
  • Assembly Biosciences, Inc.

External person

Annalisa Jenkins

  • Cell Medica
  • Inc.

External person

Corinne Price

  • Rapid Tests

External person

Jeffrey Cleland

  • President and CEO
  • Ashvatta Therapeutics
  • Graybug Vision
  • Decibel Therapeutics, Inc.

External person

Jon Frankle

  • Rapid Tests

External person

Vikas Goyal

  • Ironwood Pharmaceuticals

External person

David Grayzel

  • Atlas Venture
  • Alnylam Pharmaceuticals

External person